Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells
Colon cancer remains a clinical challenge in industrialised countries. Its treatment with 5-Flurouracil (5-FU) develops many side effects and resistance. Thus, several strategies have been undertaken so far, including the use of drug cocktails and polypharmacology. Heme oxygenase-1 (HO-1) is an emer...
Egile Nagusiak: | , , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Taylor & Francis Group
2024-12-01
|
Saila: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Gaiak: | |
Sarrera elektronikoa: | https://www.tandfonline.com/doi/10.1080/14756366.2024.2337191 |